{
  "id": "1bd3cda5e84cffd6",
  "title": "Aptar Bidose Nasal System Delivers CARDAMYST\u2122 ( etripamil ), the First and Only Self - Administered FDA - Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia ( PSVT ) ",
  "description": "20251218T040000Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2025-12-18-2/aptar-s-bidose-nasal-system-delivers-cardamyst-etripamil-the-first-and-only-self-administered-fd",
  "published_at": "20251218T040000Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2025-12-18-2/aptar-s-bidose-nasal-system-delivers-cardamyst-etripamil-the-first-and-only-self-administered-fd",
    "url_mobile": "",
    "title": "Aptar Bidose Nasal System Delivers CARDAMYST\u2122 ( etripamil ), the First and Only Self - Administered FDA - Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia ( PSVT ) ",
    "seendate": "20251218T040000Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}